Cerulean Pharma Inc. (Harvard, MIT) Closes $24 Million in Series C Financing (11/15/2010)

Cerulean Pharma is a biopharmaceutical company focused on the development of nanotechnology-based therapeutics. The company was co-founded by MIT Professor of Health Sciences & Technology and Biological Engineering Ram Sasisekahran and Harvard Medical School Assistant Professor Shiladitya Sengupta.

From the company’s press release:
Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that the Company has closed a $24 million Series C financing led by Lilly Ventures, with participation from all other existing investors including Polaris Venture Partners, Venrock, Lux Capital, and Bessemer Venture Partners. In conjunction with the closing of the financing, Steve Hall, Ph.D., a Venture Partner at Lilly Ventures, has joined Cerulean’s board of directors. read full press release

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: